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Identity 
Other names: WNT-5A 
HGNC (Hugo): WNT5A 
Location: 3p14.3 
Local order: CACNA2D3 - WNT5A - ERC2. 
Note: WNT family ligand. WNT family members with 
conserved 22 or 24 Cys residues are secreted-type 
glycoproteins, which are implicated in embryogenesis 
and carcinogenesis. Nineteen WNT family genes exist 
within the human genome. 
DNA/RNA 
Note 
WNT5A gene at chromosome 3p14.3 and WNT5B 
gene at chromosome 12p13.33 are paralogs within the 
human genome. 
Description 
WNT5A gene consists of 5 exons. First methionine is 
located in exon 1, while stop codon in exon 5. dbSNP 
rs655731, located within exon 5 of the human WNT5A 
gene, is a synonymous SNP corresponding to codon 
263. 
Transcription 
WNT5A is preferentially upregulated in gastric cancer, 
and melanoma, but downregulated in breast cancer,  
colorectal cancer, and acute lymphocytic leukemia.  
Wnt5a is upregulated by IL6 family cytokines through 
gp130 in cultured cardiomyocytes, by TGFbeta in 
mammary epithelial cells, and by TNFalpha in gastric 
cancer cells. WNT5A upregulation in primary tumor is 
in part due to stromal expression based on tumor-
stromal interaction, while WNT5A downregulation in 
primary tumor is in part due to epigenetic silencing 
induced by promoter CpG hypermethylation. 
Protein 
Description 
Mature WNT5A protein with conserved Cys residues is 
a secreted-type glycoprotein. 
Expression 
WNT5A mRNA is relatively abundantly expressed in 
salivary gland, bladder, uterus, placenta, and fetal 
kidney. 
Localisation 
Naive WNT5A protein is synthesized in the 
endoplasmic reticulum. Mature WNT5A protein with 
lipid modifications and glycosylations enters the trans-




Schematic representation of WNT5A gene. 






Atlas Genet Cytogenet Oncol Haematol. 2009; 13(5)  372 
Function 
WNT5A signals are transduced to the canonical and 
non-canonical WNT signaling cascades. WNT5A 
signaling through Frizzled-4 (FZD4) or FZD5 receptor 
and LRP5 or LRP6 co-receptor leads to the 
stabilization and nuclear accumulation of beta-catenin 
for the transcriptional activation of target genes, such 
as MYC, CCND1, and FGF20. On the other hand, 
WNT5A signaling through Frizzled family receptor or 
ROR1 or ROR2 co-receptor leads to the activation of 
the non-canonical WNT signaling cascades, such as 
DAG - PKC, IP3 - NFAT, or IP3 - NLK signaling 
cascades. WNT5A-PKC signaling promotes invasion 
and metastasis of tumors through SNAI1 (Snail)-
mediated epithelial-to-mesenchymal transition (EMT), 
while WNT5A-NLK signaling suppresses 
carcinogenesis through inhibition of the canonical 
WNT signaling cascade. Expression of WNT5A is 
associated with metastatic or aggressive phenotype in 
gastric cancer, melanoma, and osteosarcoma, but is 
associated with non-aggressive or better prognostic 
phenotype in breast cancer, colorectal cancer, and acute 
lymphocytic leukemia. Together these facts indicate 
that WNT5A induces oncogenic as well as tumor 
suppressive functions in a context-dependent manner. 
Homology 
Human WNT5A shows 98.7% total amino-acid identity 
with rodent Wnt5a, indicating that mammalian 
WNT5A orthologs are highly conserved. Among 19 




WNT5A gene is located at human chromosome 3p14.3 
around the susceptible locus of Zimmermann-Laband 
Syndrome; however, mutation of WNT5A gene has not 
been detected. 
Germinal 
Wnt5a knockout mice show smaller somites and 
shortened presomitic mesoderm, abnormalities in the 
lungs with the foreshortened trachea, dysplasia of 
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